Integrated Investment Consultants’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,767
| Closed | -$260K | – | 329 |
|
|
2025
Q1 | $260K | Sell |
1,767
-250
| -12% | -$36.2K | 0.05% | 272 |
|
|
2024
Q4 | $264K | Sell |
2,017
-142
| -7% | -$19.9K | 0.05% | 251 |
|
|
2024
Q3 | $336K | Buy |
+2,159
| New | +$349K | 0.07% | 212 |
|
|
2023
Q2 | – | Sell |
-4,428
| Closed | -$615K | – | 279 |
|
|
2023
Q1 | $615K | Sell |
4,428
-609
| -12% | -$81.9K | 0.19% | 83 |
|
|
2022
Q4 | $683K | Buy |
5,037
+74
| +1% | +$9.28K | 0.23% | 66 |
|
|
2022
Q3 | $545K | Sell |
4,963
-130
| -3% | -$16.5K | 0.22% | 72 |
|
|
2022
Q2 | $672K | Sell |
5,093
-2,310
| -31% | -$303K | 0.24% | 63 |
|
|
2022
Q1 | $982K | Sell |
7,403
-964
| -12% | -$116K | 0.28% | 59 |
|
|
2021
Q4 | $976K | Hold |
8,367
| – | – | 0.26% | 62 |
|
|
2021
Q3 | $1.01M | Buy |
8,367
+125
| +2% | +$14.6K | 0.3% | 56 |
|
|
2021
Q2 | $988K | Buy |
8,242
+3,530
| +75% | +$387K | 0.29% | 56 |
|
|
2021
Q1 | $468K | Sell |
4,712
-560
| -11% | -$56.3K | 0.16% | 118 |
|
|
2020
Q4 | $527K | Buy |
5,272
+450
| +9% | +$47.7K | 0.2% | 92 |
|
|
2020
Q3 | $528K | Buy |
4,822
+493
| +11% | +$54.8K | 0.25% | 78 |
|
|
2020
Q2 | $458K | Sell |
4,329
-790
| -15% | -$81.6K | 0.22% | 76 |
|
|
2020
Q1 | $457K | Buy |
5,119
+1,046
| +26% | +$98.5K | 0.27% | 67 |
|
|
2019
Q4 | $406K | Buy |
4,073
+746
| +22% | +$70.2K | 0.17% | 92 |
|
|
2019
Q3 | $296K | Buy |
+3,327
| New | +$288K | 0.15% | 104 |
|
|
2018
Q2 | – | Sell |
-202
| Closed | -$14K | – | 210 |
|
|
2018
Q1 | $14K | Buy |
+202
| New | +$14K | 0.01% | 584 |
|
|
2016
Q4 | – | Sell |
-1,477
| Closed | -$91K | – | 579 |
|
|
2016
Q3 | $91K | Sell |
1,477
-901
| -38% | -$58.9K | 0.05% | 287 |
|
|
2016
Q2 | $144K | Buy |
2,378
+137
| +6% | +$7.96K | 0.08% | 187 |
|
|
2016
Q1 | $132K | Buy |
+2,241
| New | +$135K | 0.08% | 175 |
|